(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.
----------
AIM - WINNERS
----------
GENinCode PLC, more than doubled at 6.625 pence, 12-month range 3.200p-9.625p. The cardiovascular disease prevention-focused genetics company said its CARDIO inCode test, for the polygenic risk assessment of coronary heart disease, is included in the US 2025 Clinical Lab Fee Schedule to enable reimbursement from Medicare and Medicaid having been "clinically adopted across leading US healthcare institutions". Says its price varies state by state, ranging from USD450 to USD570 per test. The test is also being implemented as a coronary heart disease prevention measure in Spain's Catalonia region by the local health ministry. Catalonia has up to 476,000 patients estimated to be at risk of CHD and GENinCode says it expects test volumes to reach up to 1,000 (approximately) this year. Company is also progressing its FDA submission for the test and says it expects to provide an update in the coming months.
----------
Watkin Jones PLC, up 23% at 24.45p, 12-month range 18.4p-55.6p. The developer and operator of residential rental properties says that revenue for the financial year that ended September 30 fell 12% to GBP362.4 million from GBP413.2 million. Pretax loss narrows to GBP307,000 from GBP42.5 million. Swings to basic earnings per share of 0.7p from LPS of 12.7p. Says revenue was mainly delivered through previously sold on-site developments, supported by two further developments sold in the year and the successful first year of its Refresh offering. Says administrative expenses have fallen 50% to GBP36.5 million from GBP72.8 million. Declares no dividend, continuing its approach of "prioritising the maintenance of financial flexibility" as adopted at the end of the previous year. Looking ahead, the investment market is "gradually showing signs of recovery" and for now Watkin continues to focus on "factors within our control" such as finding new sources of revenue, delivering its in-build projects, and careful cost and cash management. Adds that it remains focussed on developing its long-term pipeline.
----------
AIM - LOSERS
----------
Revolution Beauty Group PLC, down 27% at 10.59p, 12-month range 10.59p-35p. The beauty retailer expects net sales for the year ending February 28 to be down approximately 25% having "experienced some sales softness in December 2024 in its digital channels and an element of de-stocking from USA retailers". Also, "certain retailer launches" have been delayed from the fourth quarter and will now take place in the first half of financial 2026, although their scale is unchanged. However it also expects underlying adjusted earnings before interest, tax, depreciation and amortisation in the "high single digit millions...supported by the continued positive delivery of our operational and cost savings programmes". Says the current year was "transformational" with over 6,000 "unproductive" stock-keeping units discontinued "to create a scalable and profitable foundation for future growth". The discontinued SKUs made up around 75% of the company's original portfolio. Revolution Beauty says it is confident it will return to overall growth in the coming year, and anticipates "significant" medium-term margin improvements.
----------
By Emma Curzon, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Genincode (GENI)
Revolution Beauty (REVB)
Watkin Jones (WJG)
